triazolam has been researched along with Complications, Pregnancy in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakai, T | 1 |
| Matsuda, H | 1 |
| Watanabe, N | 1 |
| Attallah, A | 1 |
| Seilanian, M | 1 |
| Bavoux, F | 1 |
| Choisy, H | 1 |
2 other studies available for triazolam and Complications, Pregnancy
| Article | Year |
|---|---|
Triazolam (Halcion) intoxication in a neonate--a first report.
Topics: Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Infant, Premature; Maternal Exposure; Pois | 1996 |
[Psychotropics and pregnancy. Apropos of 2 case reports: the dose of triazolam].
Topics: Apnea; Female; Half-Life; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pr | 1989 |